United States

People: Colgate-Palmolive Co (CL.N)

CL.N on New York Stock Exchange

1:22pm EDT
Change (% chg)

$0.68 (+0.94%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Sadove, Stephen 

Mr. Stephen I. Sadove is Independent Director of Colgate-Palmolive Company. Mr. Sadove became a founding partner of JW Levin Management Partners LLC, a private equity firm, in 2015. He has also served as Principal of Stephen Sadove and Associates, which provides consulting services to the retail industry, since 2013. Mr. Sadove served as Chairman and Chief Executive Officer of Saks Incorporated (“Saks”) from 2007 until 2013. He joined Saks as Vice Chairman in 2002, served as Chief Operating Officer from 2004 to 2006 and was named Chief Executive Officer in 2006. Previously, Mr. Sadove worked for Bristol-Myers Squibb Company (“Bristol-Myers”), which he joined in 1991 as President of Clairol in the United States. He later gained additional responsibility for the consumer businesses in Canada, Europe, the Middle East, Africa and Latin America. In 1996, he was named President of Bristol-Myers’s worldwide beauty care business and was later named a senior vice president with additional responsibility for Mead Johnson Nutritionals. Mr. Sadove also serves as Chairman of the Board of Hamilton College. He has significant operational leadership experience through service as Chief Executive Officer of Saks and as head of various operating divisions at Bristol-Myers and strong knowledge of business finance and financial statements through oversight of operating budgets at various companies and financial statements at Saks. He has in-depth knowledge of fast-moving consumer goods industry through experience at Bristol-Myers. He has experience managing Bristol-Myers’s international operations. He has experience serving as a director of other U.S. public companies. He is director of Aramark Holdings Corporation from 2013, J.C. Penney Company, Inc. from 2013, Ruby Tuesday, Inc. from 2002 and Saks Incorporated from 1998 to 2013 .

Basic Compensation

Total Annual Compensation, USD 80,000
Restricted Stock Awards, USD 179,974
Long-Term Incentive Plans, USD --
All Other, USD 55,156
Fiscal Year Total, USD 315,130

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --